E-communication Disclaimer

General Terms and Conditions

Attachments that are part of this e-communication may have additional important disclosures and disclaimers, which you should read and to which you must adhere. E-communication messages may be sent from various regions and business groups. To read this relevant information, please click on any of the following categories that are applicable to this e-communication message.  Learn more about the CME Group privacy policy at cmegroup.com

General Notice

This message and any other electronic communication (i.e., email, instant message, SMS, etc.) and its attachments (an "e-communication") are intended solely for the use of the intended recipient(s) and may contain information that is privileged, confidential, proprietary or otherwise protected by work product immunity or other legal rules. No confidentiality or privilege is waived or lost by any transmission errors. If you are not an intended recipient, please delete and destroy all copies and attachments, and then please notify the sender Be advised that any review or dissemination of, or the taking of any action in reliance on, the information contained in or attached to this e-communication is strictly prohibited and in some instances doing so may be a crime. This e-communication is not intended for distribution to, or use by, any person or entity in any location where such distribution or use would be contrary to law or regulation, or which would subject the sender to any registration requirement within such location.

CME Group reserves the right to intercept, monitor, review and retain all e-communications sent to or from its systems as permitted by applicable law. Any electronic communication that is conducted within or through CME Group's systems will be subject to being archived, monitored and produced to regulators and in litigation in accordance with CME Group policy and local laws, rules and regulations.

Unless expressly prohibited by local law, electronic communications may be archived in countries other than the country in which you are located, and may be treated in accordance with the laws and regulations of the country of each individual included in the entire message chain. 

Trading Advice

Futures trading is not suitable for all investors, and involves the risk of loss. Futures are a leveraged investment, and because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money deposited for a futures position. Therefore, traders should only use funds that they can afford to lose without affecting their lifestyles. And only a portion of those funds should be devoted to any one trade because they cannot expect to profit on every trade.

Swaps trading is not suitable for all investors, involve the risk of loss and should only be undertaken by investors who are ECPs within the meaning of section 1(a) 12 of the Commodity Exchange Act. Swaps are a leveraged investment, and because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money deposited for a swaps position. Therefore, traders should only use funds that they can afford to lose without affecting their lifestyles. And only a portion of those funds should be devoted to any one trade because they cannot expect to profit on every trade.

Any research views expressed are those of the individual author and do not necessarily represent the views of the CME Group or its affiliates. 

All matters pertaining to rules and specifications herein are made subject to and are superseded by the official rules of the regulated entity. Current rules should be consulted in all cases concerning contract specifications.

Global Command Center

CME Group operates the CME Global Command Center (GCC) which is the Market Operations and Customer Service desk for electronic trading in accordance with Rule 579. The GCC handles inquiries, issues and support requests from CME Globex and CME ClearPort customers, including assistance with:

  • Electronic Trading
  • Order routing and market data interfaces
  • Network connectivity
  • CME ClearPort Facilitation
  • Cancellation of customer orders in cases of emergency

The GCC follows a specific procedure for all order status and cancellation requests. Please have all required information available before you contact the GCC.

United States: +1 800 438 8616
Europe: +44 800 898 013
Asia: +65 6532 5010
Email: gcc@cmegroup.com
www.cmegroup.com/gcc

The liability of CME Group for the negligent acts of GCC staff shall be subject to the limitations and conditions of Rule 578.

Europe

'CME,' 'CME Group,' 'CBOT,' 'NYMEX,' 'CME Direct,' 'CME Europe,' 'CME Clearing,' and 'CME Clearing Europe' are brands of CME Group Inc. and its subsidiaries' members of which include the Chicago Mercantile Exchange Inc. UK Branch (BR007101), CME Operations Limited (7306335), Elysian Systems Limited (5159458), CME Group International Market Data Limited (7694513), CME Europe Limited (8189042), CME Clearing Europe Limited (6922932), CME Trade Repository Limited (08508739), CME Benchmark Europe Limited (09165067), Globex Markets Limited (08291887), CME  Benchmark Europe Limited (09165067) and CME Marketing Europe Limited (4579008). All the above are registered in England and Wales with registered offices at One New Change, London EC4M 9AF.

Chicago Mercantile Exchange Inc. is a Recognised Overseas Clearing House (ROCH) supervised by the Bank of England in the United Kingdom.

Chicago Mercantile Exchange, Inc., Board of Trade of the City of Chicago, Inc. and New York Mercantile Exchange Inc., are Recognised Overseas Investment Exchanges (ROIEs) recognised by the Financial Conduct Authority in the United Kingdom.

CME Clearing Europe Limited is an authorised CCP under EMIR and a Recognised Clearing House (“RCH”) and Recognised Central Counterparty recognised and supervised by the Bank of England in the United Kingdom.

CME Europe Limited is a Recognised Investment Exchange (RIE) recognised and supervised by the Financial Conduct Authority in the United Kingdom.

CME European Trade Repository is a trading name of CME Trade Repository Limited, a registered trade repository under EMIR supervised by ESMA.

CME Marketing Europe Limited (FRN: 220523) is authorised and regulated by the Financial Conduct Authority for the conduct of investment business in the United Kingdom.

Globex Markets Limited (FRN: 593826) is authorised and regulated by the Financial Conduct Authority for the conduct of investment business in the United Kingdom.

CME Benchmark Europe Limited (FRN: 679696) is authorised and regulated by the Financial Conduct Authority to administer a regulated benchmark.

CME Group companies may collect and use personal data that they receive by any means. CME Group companies will only use such data in accordance with the Privacy Policy pertinent to each company which may either be accessed via its website link or by contacting the numbers set out below. Telephone calls may be recorded.

General enquiries

Telephone: +44 20 3379 3700
Fax: +44 20 3379 3888
www.cmegroup.com

CME Clearing Europe enquiries
Telephone: +44 20 3379 3100
Fax: +44 20 3379 3101
www.cmeclearingeurope.com

Asia

CME, CBOT, and NYMEX are each registered as a Recognized Market Operator in Singapore and authorized as Automated Trading Service providers in Hong Kong S.A.R. Further the information contained the e-communication does not constitute the provision of direct access with any foreign financial instrument market or clearing services for foreign financial instrument market transactions defined under Japan's Financial Instrument & Exchange Act (Law No. 25 of 1948, as amended). CME Europe Limited is not registered or licensed to provide, nor does it purport to provide financial services of any kind in any jurisdiction in Asia including Hong Kong, Singapore or Japan. None of CME Group entities are registered or licensed to provide, nor does it purport to provide, financial services of any kind in People's Republic of China or Taiwan. This e-communication is for distribution in Korea and Australia solely to "professional investors", as defined in Article 9(5) of the Financial Investment Services and Capital Markets Act and related rules and in the Corporations Act 2001 (Cth) and related rules respectively, circulation should be restricted accordingly.